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Determining which neurite of a differentiating neuron is to become the axon is a crucial 
step in neuronal morphogenesis. Two groups (Barnes et al., 2007; Shelly et al., 2007) now 
report that axon specification in vivo is mediated by extracellular signals acting through the 
serine/threonine kinase LKB1.Studies on cultured hippocampal neu-
rons have led to a model of axon speci-
fication in which young neurons start 
out with a number of neurites that are 
all equally likely to differentiate into the 
axon (Craig and Banker, 1994). In this 
model, the stochastic accumulation of 
one or several key components in one 
of the neurites makes it grow faster 
than the others and become the axon. 
A positive feedback loop acting in the 
emerging axon is then thought to fortify 
the axonal fate of this neurite. Addition-
ally, an inhibitory, negative feedback 
signal may emanate from the axon to 
prevent the other neurites from also 
choosing axonal fates. Importantly, 
both intracellular asymmetry as well 
as extracellular cues might be able to 
impart a growth advantage to one neu-
rite, leading to axon formation. Viewing 
axon specification as a competition 
between several equivalent neurites (as 
seen in culture) might not be adequate 
to account for axon formation in vivo. 
Two papers in this issue of Cell (Barnes 
et al., 2007; Shelly et al., 2007) show 
that external cues can act through the 
serine/threonine kinase LKB1 and the 
downstream SAD kinases to specify 
the axon both in vitro and in vivo.
The first molecules shown to regulate 
axon specification in cultured neurons 
were the polarity proteins par3/par6 
and atypical protein kinase C, acting 
downstream of PI3-kinase. Since then, 
many additional players have been 
shown to accumulate in the growing 
axon and to affect formation of the 
axon (reviewed in Arimura and Kaibu-
chi, 2007). For most of these proteins, downregulation or inhibition of their 
activity disrupts the formation of an 
axon, whereas overexpression leads 
to the formation of multiple axons. 
Importantly, for a few proteins, such 
as the kinase GSK3β, the opposite is 
the case: downregulation leads to the 
formation of multiple axons and over-
expression disrupts axon formation. 
Now, Barnes et al. (2007) and Shelly et 
al. (2007) identify a new player in axon 
specification, the tumor suppressor 
protein LKB1, a protein that also con-
trols epithelial polarity.
Barnes et al. (2007) disrupted 
expression of LKB1 in the murine neo-
cortex using a conditional knockout 
approach to demonstrate that LKB1 
is required for axonogenesis. In these 
mice, neuronal migration and corti-
cal layering is largely normal, but no 
axons are formed. They also show that 
activated LKB1 in a complex with the 
pseudokinase STRAD in the neocortex 
is the major activator of a set of down-
stream kinases, SAD-A and SAD-B, 
which are upstream of tau phosphor-
ylation. Given the striking penetrance of 
the phenotype of the knockout mouse, 
there is no evidence that redundant 
pathways independent of LKB1 exist 
for axon formation in the neocortex.
In complementary work, Shelly et 
al. (2007) initially characterized the 
role of LKB1 in axon formation in cul-
tured neurons. They then confirmed its 
importance in vivo using in utero elec-
troporation of plasmids that express 
an siRNA to knockdown expression of 
LKB1 in rat embryos. They also iden-
tify extracellular brain-derived neuro-Cell 1trophic factor (BDNF) as an upstream 
activator of LKB1 via the elevation 
of intracellular cAMP. Importantly, 
local presentation of BDNF in culture 
bypasses the requirement for PI3K 
activation and leads to axon formation 
even in the presence of PI3K inhibitors. 
The exact interrelationship between 
the LKB1/STRAD and PI3K signaling 
cascades remains to be determined. 
The work by Shelly et al. (2007) also 
suggests that activated LKB1, when 
in a trimeric complex with STRAD and 
MO25, is part of a positive feedback 
loop for continued LKB1 signaling in 
the growing axon. An additional mech-
anism for positive feedback is provided 
by the Rho family GTPase Rac, which 
is both downstream and upstream of 
PI3K (Arimura and Kaibuchi, 2007).
In contrast, the molecular com-
ponents involved in the postulated 
long distance negative feedback are 
unknown. Interestingly, GSK3β is con-
stitutively active in all neurites, thereby 
locally inhibiting important regula-
tors of axon growth, such as CRMP2 
(Arimura and Kaibuchi, 2007). This 
inhibition is relieved locally by activa-
tion of kinases that inactivate GSK3β in 
the growing axon (Arimura and Kaibu-
chi, 2007). Protein degradation of key 
axonal components by the ubiquitin 
proteasome system in the minor neu-
rites provides an additional negative 
regulatory mechanism that is neces-
sary for axon formation (Schwamborn 
et al., 2007; Yan et al., 2006). Whether 
a negative regulatory molecule is gen-
erated in and emanates from the axon 
(rather than just acting locally at growth 29, May 4, 2007 ©2007 Elsevier Inc. 459
cones) to suppress growth in the other 
neurites awaits further study. However, 
it is clear that the negative feedback 
can be overridden, because many 
experimental conditions lead to the 
formation of multiple axons.
Axon specification can be concep-
tualized in two ways (Arimura and Kai-
buchi, 2007; Bradke and Dotti, 2000). 
In the first, “axon fate” is determined 
by the accumulation of axon-specify-
ing components in one neurite, and 
accelerated growth is one of the axon-
specific responses set in motion down-
stream of “axonal fate” signaling. In 
the second, accelerated growth is the 
crucial initial step in axonogenesis that 
leads to the preferential accumulation 
of key axonal components in the fast 
growing process and acquisition of 
“axonal fate” downstream of growth. 
Several pieces of evidence suggest that 
growth promotion might in fact be suf-
ficient for generating an axon (Bradke 
and Dotti, 2000). The fast-growing 
neurite receives the bulk of cytoplas-
mic material in a nonspecific manner 
(Bradke and Dotti, 2000), which could 
lead to the preferential accumulation 
of axon-specific modifiers of microtu-
bules and actin, ultimately resulting in 
the differentiation of the fast-growing 
process into an axon. Work in other 
model systems (such as Caenorhab-
ditis elegans) has revealed that mol-460 Cell 129, May 4, 2007 ©2007 Elsevecules that guide and promote axon 
growth (such as netrins and Wnt) also 
promote correct axon specification (for 
example, see Adler et al., 2006). There-
fore, examining axon outgrowth in vivo 
becomes an important part of resolving 
how “fate” and “growth” are related.
A strength of the two papers in this 
issue is their in vivo analysis of axono-
genesis in the developing neocortex. 
Clearly, insights gained in cultured hip-
pocampal neurons have relevance in 
vivo, and cultured neurons remain a 
powerful model system. Yet, axonogen-
esis in the neocortex occurs differently 
than in cultured neurons. Most signifi-
cantly, imaging the cortical migration 
of newborn neurons has demonstrated 
that axons form as neurons migrate to 
their correct cortical layer. The migrat-
ing cell elaborates both a leading and 
a trailing process. The trailing process 
grows into the axon, whereas the lead-
ing process becomes the major apical 
dendrite (Hatanaka and Murakami, 
2002; Noctor et al., 2004). Rather than 
axon formation being the result of the 
competition between several equiva-
lent neurites, the direction of migration 
sets up the polarity of axon emergence. 
Other neuronal cell types have their 
own specific patterns of migration and 
of axon emergence, and the interrela-
tionship between migratory direction 
and axon formation might be different ier Inc.for different cell types. Thus, studying 
axon growth in the context of neuronal 
migration in vivo will continue to reveal 
important insights into the processes 
that underlie axon specification.
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